Hims & Hers dips into the female hair loss space
The company is now offering a topical Finasteride and Minoxidil spray as well as oral spironolactone through its virtual  care platform. (Source: mobihealthnews)
Source: mobihealthnews - January 14, 2022 Category: Information Technology Source Type: news
Janssen Showcases Commitment to Advancing Scientific Innovation in Pulmonary Arterial Hypertension (PAH) at CHEST 2021 Annual Meeting
TITUSVILLE, N.J. – October 14, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today 11* abstracts highlighting data from its pulmonary hypertension (PH) portfolio will be presented at CHEST 2021, the annual meeting of the American College of Chest Physicians, held virtually October 17-20.Data presentations from eight abstracts will provide additional evidence supporting the role of objective multiparameter risk assessment approaches in helping to optimize treatment and care for pulmonary arterial hypertension (PAH), as well as the impact of earlier and comprehensive therapy with UPTRAVIÂ...
Source: Johnson and Johnson - October 14, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
FIDELITY: Finerenone Cuts CV Risk in T2D Across CKD Spectrum FIDELITY: Finerenone Cuts CV Risk in T2D Across CKD Spectrum
Importantly, the study saw few cases of hyperkalemia associated with the drug, suggesting it avoids a major problem associated with spironolactone and eplerenone.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 29, 2021 Category: Consumer Health News Tags: Cardiology News Source Type: news
Carospir (spironolactone)
Title: Carospir (spironolactone)Category: MedicationsCreated: 8/10/2021 12:00:00 AMLast Editorial Review: 8/10/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - August 10, 2021 Category: Drugs & Pharmacology Source Type: news
FDA Recalls Some Spironolactone Bottles for Wrong Strength FDA Recalls Some Spironolactone Bottles for Wrong Strength
Four lots of prepackaged bottles of spironolactone labeled 50 mg may contain 25mg tablets, and vice versa.News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 12, 2021 Category: Cardiology Tags: Cardiology News Alert Source Type: news
Bryant Ranch Prepack Issues Voluntary Nationwide Recall of Spironolactone 25 mg and 50 mg Tablets Due to Mislabeling with the Incorrect Strength
Bryant Ranch Prepack is voluntarily recalling 4 lots of Spironolactone tablets to the consumer level. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 10, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Dec 18 2020 This Week in Cardiology Dec 18 2020 This Week in Cardiology
COVID, sacubitril/valsartan and spironolactone in patients with HFpEF, year-end comments are the topics discussed by John Mandrola, MD in this week ’s podcast.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 18, 2020 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news
FDA Panel Puts Spironolactone in Play for HF With Preserved EF FDA Panel Puts Spironolactone in Play for HF With Preserved EF
Most FDA advisers agreed data from TOPCAT were flawed but could support a new indication for the decades-old generic drug.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 17, 2020 Category: Cardiology Tags: Cardiology News Source Type: news
Spironolactone Not Tied to Breast Cancer Recurrence
Drug can be used for alopecia treatment in breast cancer survivors (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 16, 2020 Category: Cancer & Oncology Tags: Dermatology, Oncology, Pharmacy, Journal, Source Type: news
Spironolactone Not Tied to Breast Cancer Recurrence
WEDNESDAY, Sept. 16, 2020 -- Spironolactone is not independently associated with increased breast cancer recurrence, according to a study published in the October issue of the Journal of the American Academy of Dermatology.
Chapman Wei, from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 16, 2020 Category: Pharmaceuticals Source Type: news
Hair loss drug spironolactone may be safe for use in breast cancer survivors
(George Washington University) Researchers at the George Washington University have found that the hair loss drug spironolactone is not associated with increased risk of female breast cancer recurrence and may be safe to treat female pattern hair loss in breast cancer survivors. Their findings are published in the Journal of the American Academy of Dermatology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 9, 2020 Category: Cancer & Oncology Source Type: news
Evidence on Spironolactone Safety in COVID-19 Reassuring Evidence on Spironolactone Safety in COVID-19 Reassuring
Spironolactone and other androgen blockers might actually protect against the virus, Â according to a report in the Journal of the American Academy of Dermatology.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - April 29, 2020 Category: Internal Medicine Tags: Dermatology News Source Type: news
Alopecia Treatment Safe for Breast Cancer Survivors Alopecia Treatment Safe for Breast Cancer Survivors
Spironolactone is safe for the treatment of alopecia in breast cancer survivors taking endocrine therapy, new research shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 26, 2020 Category: Consumer Health News Tags: Dermatology News Source Type: news
Spironolactone Noninferior in Duchenne Muscular Dystrophy
MONDAY, Oct. 28, 2019 -- In a head-to-head study of mineralocorticoid receptor antagonists, spironolactone was found to be noninferior to eplerenone for slowing the progression of heart damage in boys with Duchenne muscular dystrophy (DMD),... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 28, 2019 Category: Pharmaceuticals Source Type: news
PRIORITY: Urine Test Spots Future Kidney Disease in Diabetes PRIORITY: Urine Test Spots Future Kidney Disease in Diabetes
Proteomic test identified patients with diabetes at high risk of kidney disease before they had detectable microalbuminuria. However, spironolactone did not mitigate the risk.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - October 3, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
